OpenAI, Sam Altman

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
As a board member he participated in Altman’s November 2023 firing ... There was this whole thing of, like, “Sam didn’t even tell the board that he was gonna launch ChatGPT.” ...